GlassScriptPhysician profile
Hubert Swana
NPI 1891732186
$1,523.99
in general payments reported to CMS, 2019-2025
10 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.23 · 2020: $47.53 · 2021: $61.34 · 2022: $46.78 · 2023: $180 · 2024: $380 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $441.99 | 2019-2024 | Speedicath, Peristeen |
| Janssen Scientific Affairs, LLC | $236.05 | 2025 | Erleada |
| Calyxo, INC. | $186.41 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $178.12 | 2024 | Deflux |
| Baxter Healthcare | $138.62 | 2024 | Floseal |
| Integra Lifesciences Corporation | $129.15 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Urogen Pharma, INC. | $125.00 | 2025 | |
| Janssen Biotech, INC. | $88.65 | 2025 | Erleada |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hubert Swana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.